Fintepla 2.2 mg/mL oral solution Images
Generic Name: fenfluramine
This medication has been identified as Fintepla 2.2 mg/mL oral solution and is used for Lennox-Gastaut Syndrome, and Dravet Syndrome. It belongs to the drug classes CNS stimulants, miscellaneous anticonvulsants and is classified as CSA Schedule 4 (Some potential for abuse).
Images of medication
Fintepla
- Generic Name
- fenfluramine
- Strength
- 2.2 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- CNS stimulants, Miscellaneous anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Zogenix, Inc.
- National Drug Code (NDC)
- 43376-0322
See also:
More about Fintepla (fenfluramine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CNS stimulants
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.